EpiHeart
PrivateLast Round
Early Funding
May 1, 2024
Est. Valuation
$5.6M
Total Funding Raised
$740,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EpiHeart operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was an Early Funding round in May 2024.
EpiHeart is a medical device company that provides a Cardiac Micrograft Therapy™ treatment to stimulate cardiac tissue recovery and improve heart function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiHeart Comparables
Compare EpiHeart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellProthera | 68% | |
| Vericel Corporation | 65% | |
| BioCardia Inc | 63% |
For institutional investors. Book with your work email.
EpiHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 1, 2024 | ||||
| Seed | Feb 22, 2021 | ||||
| Accelerator | Jun 8, 2020 |
For institutional investors. Book with your work email.
EpiHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPARK Finland | Accelerator |
| Health Incubator Helsinki | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 112% MoM, reaching 1.4K.
- May 15, 2026
Monthly visitors increased 885% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
EpiHeart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EpiHeart's valuation, stock price, and market status.
Is EpiHeart a public or private company?
EpiHeart is a private company.
What is the current stock price of EpiHeart?
EpiHeart is a private company, so its shares have no public market price. Caplight tracks EpiHeart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpiHeart worth (valuation)?
EpiHeart's valuation is estimated at $5.6M based on funding round data.
Can I buy EpiHeart stock?
EpiHeart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpiHeart's last funding round?
EpiHeart's most recent funding round was Early Funding on May 1, 2024.
Who are the main investors in EpiHeart?
Key investors in EpiHeart include SPARK Finland, Health Incubator Helsinki.
Will EpiHeart IPO soon?
No public IPO plans have been announced for EpiHeart.
How can I track EpiHeart secondary market activity?
Caplight tracks bids, offers, and trades in EpiHeart's shares on secondary markets.